Resultados de la búsqueda 101-110 of 4195 for Relapse

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... relapsed acute leukemia (AML or ALL) for future biological studies. By accruing samples both at initial diagnosis and at relapse, we will be able to ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light ...

  3. Oncología (médica) - Ensayos clínicos

    ... relapsed acute leukemia (AML or ALL) for future biological studies. By accruing samples both at initial diagnosis and at relapse, we will be able to ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... relapsed acute leukemia (AML or ALL) for future biological studies. By accruing samples both at initial diagnosis and at relapse, we will be able to ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...

  8. Oncología (médica) - Ensayos clínicos

    In particular, we plan to bank blood and bone marrow from patients with newly diagnoses or relapsed acute leukemia (AML or ALL) for future biological studies.

  9. Oncología (médica) - Ensayos clínicos

    ... relapsed acute leukemia (AML or ALL) for future biological studies. By accruing samples both at initial diagnosis and at relapse, we will be able to ...

  10. Centro Pediátrico de Mayo Clinic

    Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...